Teleflex Cash on Hand 2010-2022 | TFX

Teleflex cash on hand from 2010 to 2022. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Teleflex cash on hand for the quarter ending September 30, 2022 was $0.397B, a 17.44% decline year-over-year.
  • Teleflex cash on hand for 2021 was $0.445B, a 18.41% increase from 2020.
  • Teleflex cash on hand for 2020 was $0.376B, a 24.84% increase from 2019.
  • Teleflex cash on hand for 2019 was $0.301B, a 15.7% decline from 2018.
Teleflex Annual Cash on Hand
(Millions of US $)
2021 $445
2020 $376
2019 $301
2018 $357
2017 $334
2016 $544
2015 $338
2014 $303
2013 $432
2012 $337
2011 $584
2010 $208
2009 $188
Teleflex Quarterly Cash on Hand
(Millions of US $)
2022-09-30 $397
2022-06-30 $308
2022-03-31 $467
2021-12-31 $445
2021-09-30 $481
2021-06-30 $362
2021-03-31 $325
2020-12-31 $376
2020-09-30 $347
2020-06-30 $554
2020-03-31 $406
2019-12-31 $301
2019-09-30 $258
2019-06-30 $304
2019-03-31 $271
2018-12-31 $357
2018-09-30 $356
2018-06-30 $346
2018-03-31 $379
2017-12-31 $334
2017-09-30 $1,018
2017-06-30 $676
2017-03-31 $689
2016-12-31 $544
2016-09-30 $499
2016-06-30 $476
2016-03-31 $393
2015-12-31 $338
2015-09-30 $276
2015-06-30 $325
2015-03-31 $309
2014-12-31 $303
2014-09-30 $286
2014-06-30 $237
2014-03-31 $422
2013-12-31 $432
2013-09-30 $326
2013-06-30 $281
2013-03-31 $307
2012-12-31 $337
2012-09-30 $635
2012-06-30 $545
2012-03-31 $591
2011-12-31 $584
2011-09-30 $372
2011-06-30 $366
2011-03-31 $202
2010-12-31 $208
2010-09-30 $248
2010-06-30 $287
2010-03-31 $211
2009-12-31 $188
2009-09-30 $159
2009-06-30 $114
2009-03-31 $143
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $12.124B $2.810B
Teleflex is a global provider of medical technology products. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company markets and sells its products to hospitals and healthcare providers worldwide through a combination of direct sales force and distributors. Teleflex has manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $230.517B 25.29
Edwards Lifesciences (EW) United States $50.772B 33.11
Alcon (ALC) Switzerland $37.369B 32.17
STERIS (STE) Ireland $21.864B 27.21
Fresenius Medical Care AG KGaA (FMS) Germany $11.123B 11.16
Penumbra (PEN) United States $9.913B 2372.91
Globus Medical (GMED) United States $7.950B 40.42
Glaukos (GKOS) United States $2.458B 0.00
Integer Holdings (ITGR) United States $2.435B 19.55
AVANOS MEDICAL, INC (AVNS) United States $1.469B 20.92
Nevro (NVRO) United States $1.410B 0.00
Paragon 28 (FNA) United States $1.346B 0.00
Artivion (AORT) United States $0.566B 0.00